1Gerli R, Caponi L. Anti-ribosomal P protein antibodies[J]. Autoimmunity, 2005, 38(1):85-92.
2Arnett FC, Reveille JD, Moustopoulos HM, et al. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetie asso- ciation[J]. Arthritis Rheum, 1996, 39(11) :1833-1839.
3Isenberg DA, Garton M, Reichlin MW, et al. long-term fol- low-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients[J]. Br J Rheumatol, 1997, 136(2) ,229-233.
4Koren E, Schnitz, Reichlin M. Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus[J]. Arthritis Rheum, 1993, 36(9):1325-1328.
5Yoshio T, Masuyama JI, Minota S, et al. A close temporal relationship of liver disease to antiribosomal P0 protein anti- bodies and central nervous system disease in patients with sys- temic lupus erythematosus[J]. J Rheumatol, 1998, 25 (4) : 681-688.
6Monova D, Argirova T, Monov S, et al. Antiribosomal P an- tibodies in patients with lupus glomerulonephritis [J]. Clin Nephrol, 2001, 55(5):425-426.
7Haddouk S, Marzouk S, Jallouli M, et aL Clinical and diag- nostic value of ribosomal P autoantibodies in systemic lupus er- ythematosus[J]. Rheumatology (Oxford), 2009, 48 (8) : 953- 957.
8Hochberg MC. Updating the American College of Rheumatol- ogy revised criteria for the classification of systemic lupus ery- thematosus[J]. Arthritis Rheum, 1997, 40(9) : 1725.
9The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes[J]. Arthritis Rheum, 1999,42(4) :599-608.
10Bombardier C, Gladman DD, Urowitz MB, et al. The Com- mittee on Prognosis Studies in SLE. Derivation of the SLE- DAI. A disease activity index for lupus patients[J]. Arthritis Rheum, 1992, 35(6) :630-640.
